Adjuvant aromatase inhibitors and emerging quality-of-life considerations

被引：3

|

作者：

Briest, Susanne ^{[1
]}

Stearns, Vered ^{[2
]}

机构：

[1] Univ Leipzig, Dept Gynecol & Obstet, Leipzig, Germany

[2] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2008年 / 8卷 / 01期

关键词：

D O I：

10.1586/14737140.8.1.1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1 / 4

页数：4

相关论文

共 50 条

[21] Safety of aromatase inhibitors in the adjuvant setting
Perez, Edith A.
BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (Suppl 1) : 75 - 89
[22] Safety of aromatase inhibitors in the adjuvant setting
Edith A. Perez
Breast Cancer Research and Treatment, 2007, 105 : 75 - 89
[23] Adjuvant aromatase inhibitors - Are we there yet?
Gini, F
Fleming, MD
CANCER, 2003, 98 (09) : 1779 - 1781
[24] Adjuvant aromatase inhibitors for breast cancer
Howell, A
LANCET, 2005, 366 (9484): : 431 - 433
[25] Role of Adjuvant Therapy in Postsurgical Quality-of-Life and Functional Impairment
Haughey, Bruce H.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2013, 139 (11) : 1109 - 110
[26] QUALITY-OF-LIFE IN LUNG-CANCER SURGICAL ADJUVANT TRIALS
RUCKDESCHEL, JC
PIANTADOSI, S
CHEST, 1994, 106 (06) : S324 - S328
[27] IMPROVING QUALITY-OF-LIFE - ADJUVANT PSYCHOLOGICAL THERAPY FOR PATIENTS WITH CANCER
GREER, S
SUPPORTIVE CARE IN CANCER, 1995, 3 (04) : 248 - 251
[28] ANGIOTENSIN CONVERTING ENZYME-INHIBITORS AND QUALITY-OF-LIFE
BRECKENRIDGE, A
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (01) : S79 - S82
[29] Drug Treatment of Overactive BladderEfficacy, Cost and Quality-of-Life Considerations
Hashim Hashim
Paul Abrams
Drugs, 2004, 64 : 1643 - 1656
[30] IMPLEMENTING QUALITY-OF-LIFE STUDIES CLINICAL INVESTIGATIONS - METHODOLOGICAL CONSIDERATIONS
AARONSON, NK
QUALITY OF LIFE RESEARCH, 1993, 2 (01) : 59 - 59

← 1 2 3 4 5 →